Share on LinkedInShare on LinkedIn

ARTICLE · 19 DECEMBER 2014

Fetal Diagnostics Patent Claims Fall In Inter Partes Review

Post grant inter partes review proceedings have lowered the hurdle to invalidate U.S. patents.

United StatesIntellectual Property

Post grant inter partes review proceedings have lowered the hurdle to invalidate U.S. patents. The "broadest reasonable construction" of the claims and the lower burden to prove invalidity (by a preponderance of the evidence) of inter partes review proceedings have resulted in many successful challenges. Indeed, the Patent Trial and Appeal Board (PTAB) of the USPTO recently invalidated all challenged claims of a patent claiming methods to diagnose fetal abnormalities. In Ariosa Diagnostics v. The Board of Trustees of the Leland Stanford Junior University (IPR2013-00308) ("Decision") the PTAB invalidated 13 claims of U.S. Patent No. 8,296,076 entitled "Noninvasive Diagnosis of Fetal Aneuoploidy by Sequencing" ("the '076 Patent") assigned to the Board of Trustees of the Leland Stanford Junior University ("Stanford").

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from